Globeflex Capital L P Regenxbio Inc. Transaction History

Globeflex Capital L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$42.0 - $59.29 $316,218 - $446,394	-7,529 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$40.82 - $62.45 $46,085 - $70,506	1,129 Added 17.64%	7,529 $431,000
Q3 2018 Nov 09, 2018	BUY	$65.0 - $82.15 $52,000 - $65,720	800 Added 14.29%	6,400 $483,000
Q2 2018 Aug 10, 2018	BUY	$27.2 - $74.35 $152,320 - $416,359	5,600 New	5,600 $402,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $313M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.